Smoking behaviour of patients before and after renal transplantation.

Smoking behaviour of patients before and after renal transplantation. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Smoking behaviour of patients before and after renal transplantation. Abstract Text:

Miriam C Banas,Bernhard Banas,Johanna Wolf,Ute Hoffmann,Bernd ,Carsten A ,Stephan R Orth,Bernhard K ,

BACKGROUND: Smoking is the most important remediable cardiovascular risk factor, and an independent risk factor for the progression of renal diseases. To date, only limited information about changes in cigarette-smoking habits before and after renal transplantation is available. METHODS: In a comprehensive cross-sectional single centre study, we analysed smoking habits of patients registered on the waiting list for renal transplantation and patients that had received an allograft. RESULTS: Of 230 patients (76.1%), 175 on the waiting list and of 264 allograft recipients (87.5%), 231 were non-smokers at the time of investigation (P <0.01). Among the non-smoking waiting list patients, only 71 (30.9%) had never smoked, whereas 108 (40.9%) patients of the allograft recipients were never-smokers. Of former smoking patients, 27.6% (n = 34) had stopped smoking after transplantation. Patients <55 years of age and females were more likely to stop smoking than patients >55 years of age or males. A data analysis revealed that smokers had a significantly lower probability to attain renal transplantation. CONCLUSION: We conclude that renal transplantation is a strong incentive for patients to stop smoking. Reasons for changes in smoking behaviour after renal transplantation may be an intense contact of the patients with their physicians, the fear of a premature loss of the transplanted organ with continued smoking and the psychological support during post-transplantation patient care.

Smoking behaviour of patients before and after renal transplantation. Publishing Authors By Initials

MC Banas,B Banas,J Wolf,U Hoffmann,B ,CA ,SR Orth,BK ,

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Smoking behaviour of patients before and after renal transplantation. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: Nephrology, dialysis, transplantation : official p

VOLUME: 23

Page Numbers: 1442-6

Journal Abbreviation: Nephrol. Dial. Transplant.

ISSN: 1460-2385

DAY: 8

MONTH: 12

YEAR: 2007

Smoking behaviour of patients before and after renal transplantation. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 8706402

Smoking behaviour of patients before and after renal transplantation. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Smoking behaviour of patients before and after renal transplantation. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Smoking behaviour of patients before and after renal transplantation.

AFFILIATION: Klinik und Poliklinik für Innere Medizin II, University of Regensburg, D-93042 Regensburg, Germany. miriam.banas@klinik.uni-regensburg.de

Country: England

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Nephrol Dial Transplant

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Smoking behaviour of patients before and after renal transplantation Related Publications

• Adrenal aldosterone biosynthesis is elevated in a model of chronic renal failure--role of local adrenal renin-angiotensin system.
• Allosteric control of oligonucleotide hybridization by metal-induced cyclization.
• Alpha-tocopherol influences the lipid membrane affinity of desipramine in a pH-dependent manner.
• Assessing Psychological Stress among Arab Migrant Women in the City of Cologne/Germany Using the Community Oriented Primary Care (COPC) Approach.
• Bi5O7Br and its structural relation to alpha-Bi5O7I.
• Changes and measurement of height and angle in the lumbosacral region.
• Contribution of smoking and air pollution exposure in urban areas to social differences in respiratory health.
• Dynamics and Cleavability at the {alpha}-Cleavage Site of APP(684-726) in Different Lipid Environments.
• Effect of membrane flux and dialyzer biocompatibility on survival in end-stage diabetic nephropathy.
• Factors associated with lack of postnatal care among Palestinian women: a cross-sectional study of three clinics in the West Bank.
• Hook2 contributes to aggresome formation.
• JAK2-V617F and BCR-ABL-Double Jeopardy?
• No effect of C-reactive protein (CRP) haplotypes on CRP levels and post-transplant morbidity and mortality in renal transplantation.
• Osmolality, temperature, and membrane lipid composition modulate the activity of betaine transporter BetP in Corynebacterium glutamicum.
• P-glycoprotein in proteoliposomes with low residual detergent: the effects of cholesterol.
• Pharmacy and pharmacology of biosimilars.
• Physicochemical compatibility of fluticasone-17- propionate nebulizer suspension with ipratropium and albuterol nebulizer solutions.
• Predictors of overweight and obesity in five to seven-year-old children in Germany: results from cross-sectional studies.
• Prevalence of overweight and obesity in East and West German children in the decade after reunification: population-based series of cross-sectional studies.
• Smoking behaviour of patients before and after renal transplantation.
• Telmisartan, ramipril, or both in patients at high risk of vascular events.
• The biochemistry of drug metabolism--an introduction: part 3. Reactions of hydrolysis and their enzymes.
• The endoscopic treatment of carpal tunnel syndrome as an outpatient procedure.
• Ultrastructural evidence of dermal gadolinium deposits in a patient with nephrogenic systemic fibrosis and end-stage renal disease.
• [Characteristics of pharmacotherapy of epilepsy in the elderly]
• [Endovascular therapy of infrarenal aortic aneurysms: preinterventional imaging and follow-up.]
• [Epileptic seizures and epilepsy in the elderly]
• [Gabapentin (Neurontin): a new possibility in the add-on therapy of partial epilepsies]
• [Health statistics as a principle in health planning]
• [Neurobehavioral and systemic effects in lead-exposed rats after an exposure-free interval of four months duration (author's transl)]